Injection Drug Use-Associated HIV, HCV Risk Higher in Women, Younger Individuals
Researchers evaluated global data on HIV infection and primary hepatic C virus infection incidence among injections drug users.
Diagnosis & Disease Information
Men Break Too: Recognizing the Role of Liver Disease in Osteoporosis
Nonalcoholic fatty liver disease and alcoholic liver disease are underrecognized causes of osteoporosis in men.
Point-of-Care HCV Testing Improves Treatment Uptake, Time to Initiation
Researchers compared hepatitis C virus point-of-care RNA viral load testing with laboratory-based testing to determine the effects on treatment uptake and turnaround times.
Liver May Be Reservoir for HIV DNA in Patients With HBV Coinfection on ART
Researchers evaluated whether HIV DNA persists in the liver among individuals receiving suppressive antiretroviral therapy.
NPs, PAs Needed to Treat Growing Rates of Liver Disease
Liver disease and cirrhosis now outpace diabetes and stroke as the leading cause of mortality in people aged 25 to 54 years. New survey results shows shortfalls in adoption of national treatment guidelines for liver disease and cirrhosis.
Treatment for Hepatitis C Up Among People Who Inject Drugs
Among persons who inject drugs with chronic HCV infection, proportion with detectable HCV RNA decreased from 100% in 2006 to 48% in 2019.
No Increase Seen in Pediatric Hepatitis in the United States
No increase in acute hepatitis of unspecified etiology, adenovirus types 40/41 above prepandemic baseline levels.
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis.
Testing, Treatment Initiations for Hepatitis C Decreased During the COVID-19 Pandemic
In this study, researchers assessed the nationwide rate of testing and treatment initiations for hepatitis C virus infection in the United States following the onset of the COVID-19 pandemic through the end of 2020.
High Immunogenicity Observed Among Healthy Adults After 3 Doses of the 3-Antigen Formulation Hepatitis B Vaccine
Investigators assessed the manufacturing consistency, safety, and efficacy of a 3-antigen hepatitis B vaccine vs a single-antigen formulation.
- Loading...
Loading...
Next post in Gastroenterology Information Center
Loading... 
Loading...